LabRoots Continues Expert-Driven Coronavirus Virtual Event Series Addressing Origins of the Virus, Clinical Manifestations, and Testing, Diagnostics and Prevention
This online event, 4th in the series scheduled on December 3rd, facilitates academic and industry collaboration across healthcare verticals in response to the evolving COVID-19 global pandemic
YORBA LINDA, Calif., Dec. 1, 2020 /PRNewswire-PRWeb/ -- LabRoots, the leading scientific social networking website offering premier, interactive virtual events and webinars, today announced the last event as part of its ongoing free Coronavirus Virtual Event Series hosted on December 3rd, 2020, covering the impacts of the coronavirus disease. The preceding events with on demand presentations (April 2, June 17 and September 17) held record attendance, and this upcoming conference promises to generate resumed hot topics and expanded awareness.
The virtual stage comprising over 12,000 research scholars, healthcare and medical experts, clinicians, top scientists and epidemiologists, and industry and academia professionals from around the world, features a jam-packed agenda highlighting wide-ranging topics.
Key sessions include, transmission dynamics of SARS-CoV-2: Inference and Projection, the Immunology of COVID-19, via a joint panel session sponsored by Nanostring Technologies to better understand the current knowledge on the dynamics of the immune response, followed by a second panel opportunity on Advancing SARS-CoV-2 Testing Today and a New Serology Approach for High Throughput Screening, sponsored by LGC Seracare. Moreover, Dr. Linfa Wang, Professor and Director, Emerging Infectious Diseases, Duke-NUS Medical School will provide a review of major emerging zoonotic virus outbreaks, in addition to other notable speaker presentations on COVID-19 RNA and DNA vaccines; an Iterative Approach to Structure-based insilico to in vivo Development of Combinatorial Anti-SARS-CoV-2 Therapy; Development, assessment and commercialization of serological SARS Cov-2 tests; NGS Workflows for Studying Infectious Disease; Putting Covid-19 into Context; and Immunity, Aging and COVID-19: where do we stand, naming other talk titles.
With rapidly shifting developments and advancements, it's important to unveil such valuable insights from the following prominent speakers through their keynote deliveries:
Monica Gandhi, MD, MPH, Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, Global Medicine, UCSF, Director, UCSF-Gladstone Center for AID Research (CFAR) – "Facial Masking for COVID-19: Transmission, Severity and Immunity."
Matthew J. Memoli, MD, MS, Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) – "Prevalence of SARS-Co-V-2 Immunity in Those Undiagnosed with COVID-19 in the U.S." discussing immunity, antibody testing and the meaning of these tests and the findings of the NIH serosurvey in terms of immunity by geography and demographic groups.
Ali H. Mokdad, PhD, Chief Strategy Officer, Population Health, University of Washington, Director, Middle Eastern Initiatives, Professor, Health Metric Sciences, Institute for Health Metrics and Evaluation, School of Medicine – "COVID-19 Projections for the United States," revealing the drivers of COVID-19 surge, the projected numbers of cases and deaths, and the measures to contain the virus.
"Non-pharmaceutical interventions for COVID-19 prevention (facial masks, social distancing, hand hygiene, and ventilation) have been pivotal for prevention efforts to date and will continue to play a role in COVID-19 mitigation as we go through the process of achieving equitable distribution of a safe and effective vaccine," commented Dr. Monica Gandhi, Infectious Diseases Doctor, Professor, and Director of the UCSF Center of AIDS Research at UCSF." Gandhi added, "Facial masking is a cornerstone of the COVID-19 pandemic control but has had controversy. This talk will go over the epidemiologic data on facial masks curbing SARS-CoV-2 transmission, the physical sciences data on how masks protect both you and others, and the role of NPIs in reducing viral inoculum which may reduce the severity of disease if infected."
Matthew Memoli, Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID/NIH said, "Respiratory viruses like COVID-19 and Influenza challenge scientists to explore the complexity of the immune response and correlates of protection. Broad investigation using translational studies in humans are imperative to our efforts to design efficacious, balanced countermeasures in an informed way that will lead to significant success in limiting the deleterious impact of these infections without destroying society or removing our humanity."
"We have been fortunate to have various informative and enlightening discussions shared by renowned experts tackling some of the biggest questions facing the world today over the duration of our Coronavirus Virtual Event Series this year," said Greg Cruikshank, Chief Executive Officer of LabRoots. "During this COVD-19 pandemic and other future events, LabRoots will continue to be a source of bringing educational content to the forefront to empower the life sciences community, while presenting lessons learned and best practices for mitigation, preparedness, response and recovery strategies making a larger impact in the response to COVID-19 and human health, now and in the future."
Produced on LabRoots' robust platform while connecting across all desktop and mobile devices, the interactive environment is complete with a lobby, auditorium, poster hall, exhibit hall (driving innovations and highlighting the latest products and technologies), and networking lounge (encouraging collaborations), providing a one-stop learning experience for all attendees. By participating in this virtual event series, you can earn 1 Continuing Education credit per presentation.
For more information or to register for the event, click here. Participants can follow the conversation online by using #LRcoronavirus.
About LabRoots
LabRoots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.
Media Contact
Lynn Brainard, LabRoots, 7174-771-4397, [email protected]
SOURCE LabRoots
Share this article